Research & Development
Neuroscience is deeply rooted within Ipsen as a key strategic driver for our business. Through our strategy in external innovation, we are actively expanding our pipeline into neurodegenerative disorders .
€2869.9 M
Total sales 2021
+12.3 % YOY
€2153.5 M
2021 Oncology sales
+10.8 % YOY
35.2%
Record core
operating margin
€440.7 M
2021 Rare disease sales
-10.4% YOY